Read + Share
Li R, Chen X, Wang Y. Adverse events analysis of Relugolix (Orgovyx(R)) for prostate cancer based on the
FDA Adverse Event Reporting System (FAERS). PLoS One 2024;19:e0312481.
PMID: 39436909
|
 |
|
Li R, Chen X, Wang Y. Adverse events analysis of Relugolix (Orgovyx(R)) for prostate cancer based on the
FDA Adverse Event Reporting System (FAERS). PLoS One 2024;19:e0312481.
PMID: 39436909
|
|
|
|